Rosfion

Rosfion is indicated for :

Patients with primary hypercholesterolaemia (type lla, including heterozygous familial hypercholesterolaemia) or mixed dyslipidemia (type llb) as an adjunct to diet when response to diet and exercise is inadequate.
Reduces elevated LDL-cholesterol, total cholesterol, triglycerides and ApoB, and increases HDL-cholesterol
Patients with homozygous familial hypercholesterolaemia as an adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis)

Short Description

Rosfion with active ingredient Rosuvastatin calcium (equivalent with Rosuvastatin) is available in 20 mg film coated tablet

Rosfion is indicated for :

Patients with primary hypercholesterolaemia (type lla, including heterozygous familial hypercholesterolaemia) or mixed dyslipidemia (type llb) as an adjunct to diet when response to diet and exercise is inadequate.
Reduces elevated LDL-cholesterol, total cholesterol, triglycerides and ApoB, and increases HDL-cholesterol
Patients with homozygous familial hypercholesterolaemia as an adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis)

Oral

Rosfion Film Coated Tablet 20 mg

Box, 3 blisters @ 10 film coated tablets